| Date | Title | Description |
| 19.09.2025 | Closed Loop Medicine launches first personalized GLP-1 dosing platform in U.S. | WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence.
Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration and r... |
| 21.05.2025 | Closed Loop Medicine appoints Kate Woolland as CEO | Leadership transition to drive commercialization strategy in deploying and scaling proven platform and therapy-specific precision dosing technologies
Closed Loop Medicine Ltd. (“CLM”), a leader in pharmaceutical precision dosing, today anno... |
| 21.05.2025 | Woolland steps up to steer fresh growth phase for Closed Loop Medicine | - |
| 24.03.2025 | US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies | London, UK, 24 March 2025: Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, announces the expansion of its US patent portfolio. Strengthening its cardiometabolic treatment portfolio, the Company now has patents coverin... |
| 22.12.2024 | The Digital Revolution in Healthcare: Monitoring Blood Pressure Remotely | In the age of technology, healthcare is undergoing a seismic shift. Digital platforms are becoming the backbone of patient monitoring. Closed Loop Medicine, a pioneer in this field, has unveiled a groundbreaking study that showcases the pot... |
| 17.12.2024 | Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring | Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients
Findings support the use of the Company’s combined drug + digit... |
| 13.09.2024 | The New Wave of Healthcare Innovation: Leaders Shaping the Future | The healthcare landscape is evolving. Two recent appointments highlight this shift. Closed Loop Medicine and Highlander Health are at the forefront, steering the ship toward a more personalized and efficient future. Closed Loop Medicine, a ... |
| 11.09.2024 | Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors | Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones
London, UK, 11 Sep 2024: Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine le... |
| 27.03.2024 | Teva UK partners Closed Loop on personalised medicine | - |
| 26.03.2024 | Teva UK and Closed Loop Medicine announce partnership to advance personalised medicines | - |
| 26.03.2024 | Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines | Castleford and London: Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicine.
Under the agreement, Closed Loop Medicine – a leading TechBio company – and phar... |
| 26.03.2024 | Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines | Castleford and London, UK, 26th March 2024: Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicine.
Under the agreement, Closed Loop Medicine – a leading Tech... |
| 08.02.2024 | Closed Loop Medicine demonstrates application of novel drug plus software product for personalized treatment of hypertension | London, UK, Thursday 8th February 2024: Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, today announced the publicatio... |
| 08.02.2024 | Closed Loop Medicine demonstrates application of novel drug plus software product for personalized treatment of hypertension | Study published in JAHA validates use of proprietary technology to identify personalized dose regimen, leading to improved blood pressure control and exceptionally high adherence in hypertension patients
Findings will guide the Company’s st... |
| 08.02.2024 | Closed Loop Medicine advances smartphone-enabled precision medicine | - |
| 08.02.2024 | Closed Loop Medicine advances smartphone-enabled precision medicine | Today, the UK biotech company Closed Loop Medicine announced the publication of a peer-reviewed study in the Journal of the American Heart Association.
Founded in 2017, Closed Loop is developing combination prescription drug plus software t... |
| 25.01.2024 | Six new investments, portfolio progress and an expanding investment team | Clare Terlouw, Head of LifeArc Ventures, said: “Our portfolio of investments expanded during the year and despite challenging financing conditions in the sector we were pleased to invest in six new companies and to continue to support our e... |
| 20.06.2023 | Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer | Key executive appointment supports strategic operational delivery of the Company’s product and partnership programs
Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products... |
| 22.03.2022 | Closed Loop Medicine announces completion of Precision Medicine Clinical Trial for patients with high blood pressure | Closed Loop Medicine announces completion of Precision Medicine Clinical Trial for patients with high blood pressure
22-03-2022
Cambridge and London: Closed Loop Medicine Ltd, a leader in the development of single prescription drug plus dig... |
| 03.11.2021 | LifeArc invests in company developing personalised drug and digital combination treatments | The deal was led by Ananda Impact Ventures and BGF, and involved a strong syndicate of investors including LifeArc, Longwall, Meltwind, IQ Capital, Downing Ventures and Cambridge Angels.
This new investment will enable the company to devel... |
| 03.11.2021 | LifeArc invests in company developing personalised drug and digital combination treatments | Closed Loop Medicine today announced they have completed a £13 million financing deal to advance their personalised drug and digital therapy combination products to enable precision dosing.
The deal was led by Ananda Impact Ventures and BG... |
| 03.11.2021 | London’s Closed Loop Medicine that develops drug plus digital therapy closes £13M funding | London-based Closed Loop Medicine is one of the UK’s leading pioneers in digital/therapeutic medicine. The company just announced that it has closed £13 million in a new Series A investment round that came from a slew of top UK and European... |
| 02.11.2021 | Closed Loop Medicine closes £13 million to finance its personalised drug + digital therapy (DTx) combination products to improve outcomes for patients through precision dosing | Closed Loop Medicine has closed £13 million GBP (c. $17million USD) of new investment from a range of top UK and European venture capital investors. The money has been raised to finance its personalised drug + digital therapy (DTx) combinat... |
| 05.08.2020 | Closed Loop Medicine secures £250,000 Innovate UK continuity funding | Closed Loop Medicine has secured £250,000 from Innovate UK to support clinical evaluation of a drug + digital combination product for hypertension and COVID- 19 monitoring.
Closed Loop Medicine (CLM), the Babraham Research Campus therapeuti... |
| 05.08.2020 | Closed Loop Medicine secures £250,000 Innovate UK continuity funding | Closed Loop Medicine secures £250,000 Innovate UK continuity funding
05-08-2020
Closed Loop Medicine has secured £250,000 from Innovate UK to support clinical evaluation of a drug + digital combination product for hypertension and COVID- 19... |
| 28.07.2020 | London-based Closed Loop Medicine secures €275K for COVID-19 and hypertension monitoring | Closed Loop Medicine (CLM), a London based therapeutics and healthtech startup, announced to raise approx. €275K COVID-19 Innovate UK Continuity Funding award in order to support its ongoing clinical research programme previously secured th... |
| 26.07.2020 | Closed Loop Medicine secures Euro 275k COVID-19 Innovative UK Continuity Funding Award | London: British startup Closed Loop Medicine (CLM), a therapeutics and healthtech startup, has secured an approx. €275K COVID-19 Innovate UK Continuity Funding award to support its ongoing clinical research programme previously secured thro... |
| 24.07.2020 | Closed Loop Medicine Secures £250K in Funding | Closed Loop Medicine, a London, UK-based therapeutics and health tech company, secured £250k COVID-19 Innovate UK Continuity Funding award.
The funding will support the company’s ts ongoing clinical research program previously secured throu... |
| 24.07.2020 | London-based Closed Loop Medicine secures €275K for COVID-19 and hypertension monitoring | British startup Closed Loop Medicine (CLM), a therapeutics and healthtech startup, has secured an approx. €275K COVID-19 Innovate UK Continuity Funding award to support its ongoing clinical research programme previously secured through the ... |
| 10.05.2019 | Closed Loop Medicine raises £2.1 million pre-Series A | Closed Loop Medicine raises £2.1 million pre-Series A
10-05-2019
Closed Loop Medicine (CLM) - the Cambridge-based health tech startup that helps doctors and healthcare providers to deliver personalised treatment regimens - has raised £2.1 m... |
| 10.05.2019 | Closed Loop Medicine raises £2.1 million pre-Series A | Closed Loop Medicine (CLM) - the Cambridge-based health tech startup that helps doctors and healthcare providers to deliver personalised treatment regimens - has raised £2.1 million in venture capital funding. |
| 10.05.2019 | Closed Loop Medicine Raises £2.1M in Pre-Series A Funding | Closed Loop Medicine, a Cambridge, and London, UK-based health tech startup, raised £2.1M in Pre-Series A funding.
Backers included Longwall Venture Partners, IQ Capital and Martlet, the investment arm of the Marshall of Cambridge group, as... |
| - | BGF completes significant follow-on funding investment in Closed Loop Medicine | BGF has completed a significant follow-on investment in Closed Loop Medicine, the global leader in the development of single prescription drug plus digital therapy (DTx) combination products.
The £13 million investment has been raised to f... |
